The DOI matches its Crossref record; 143 of the 143 references it cites were found in a registry or an index.
Apoptosis and melanoma chemoresistance
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Apoptosis: A Basic Biological Phenomenon with Wideranging Implications in Tissue Kinetics
Kerr, J. F. R., Wyllie, A. H., & Currie, A. R. (1972) · British Journal of Cancer · doi:10.1038/bjc.1972.33 · Cited by 15,725
Mutations of the BRAF gene in human cancer
Davies, H., Bignell, G. R., Cox, C., Stephens, P., Edkins, S., Clegg, S., Teague, J., Woffendin, H., Garnett, M. J., Bottomley, W., et al. (2002) · Nature · doi:10.1038/nature00766 · Cited by 10,674 · cited 1×
“Mutations are restricted to a few single amino-acid changes (primarily on V599) that render a constitutive active kinase with transforming properties in NIH3T3 cells (Davies et al., 2002).”
BackgroundGreen, D. R., & Reed, J. C. (1998) · Science · doi:10.1126/science.281.5381.1309 · Cited by 8,965
Thornberry, N. A., & Lazebnik, Y. (1998) · Science · doi:10.1126/science.281.5381.1312 · Cited by 6,887
Death Receptors: Signaling and Modulation
Ashkenazi, A., & Dixit, V. M. (1998) · Science · doi:10.1126/science.281.5381.1305 · Cited by 5,866
The phosphoinositide 3-kinase pathway
Cantley, L. C. (2002) · Science · doi:10.1126/science.296.5573.1655 · Cited by 5,621
The Bcl-2 Protein Family: Arbiters of Cell Survival
Adams, J. M., & Cory, S. (1998) · Science · doi:10.1126/science.281.5381.1322 · Cited by 5,332
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218 · cited 1×
“One of these genes is the product of the p16INK4a gene (Serrano et al., 1997), also associated with senescence of human melanocytes and inactivated in melanoma (Bennett and Medrano, 2002).”
BackgroundSelf-citationBIOCHEMISTRY OF MULTIDRUG RESISTANCE MEDIATED BY THE MULTIDRUG TRANSPORTER
Gottesman, M. M., & Pastan, I. (1993) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.62.070193.002125 · Cited by 3,568
Hannon, G. J. (2002) · Nature · doi:10.1038/418244a · Cited by 3,538
Jemal, A., Thomas, A., Murray, T., & Thun, M. (2002) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.52.1.23 · Cited by 2,917
NF-κB at the crossroads of life and death
Karin, M., & Lin, A. (2002) · Nature Immunology · doi:10.1038/ni0302-221 · Cited by 2,709 · cited 2×
“In the context of cell death control, NFkB modulates the expression of a plethora of survival factors that interfere with mitochondrial and death receptor-mediated apoptosis (Karin and Lin, 2002) (see Figure 2).”
BackgroundProgrammed Cell Death in Animal Development
Jacobson, M. D., Weil, M., & Raff, M. C. (1997) · Cell · doi:10.1016/s0092-8674(00)81873-5 · Cited by 2,698
Final Version of the American Joint Committee on Cancer Staging System for Cutaneous Melanoma
Balch, C. M., Buzaid, A. C., Soong, S.-J., Atkins, M. B., Cascinelli, N., Coit, D. G., Fleming, I. D., Gershenwald, J. E., Houghton, A., Kirkwood, J. M., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.16.3635 · Cited by 2,636
Biochemical Pathways of Caspase Activation During Apoptosis
Budihardjo, I., Oliver, H., Lutter, M., Luo, X., & Wang, X. (1999) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.15.1.269 · Cited by 2,565
Inhibition of death receptor signals by cellular FLIP
Irmler, M., Thome, M., Hahne, M., Schneider, P., Hofmann, K., Steiner, V., Bodmer, J.-L., Schröter, M., Burns, K., Mattmann, C., et al. (1997) · Nature · doi:10.1038/40657 · Cited by 2,563
Death and anti-death: tumour resistance to apoptosis
Igney, F. H., & Krammer, P. H. (2002) · Nature Reviews Cancer · doi:10.1038/nrc776 · Cited by 2,075
Johnstone (2002) · doi:10.1016/s0092-8674(02)00625-6 · Cited by 1,876
Lowe, S. W., & Lin, A. W. (2000) · Carcinogenesis · doi:10.1093/carcin/21.3.485 · Cited by 1,876
Self-citationControl of apoptosis and mitotic spindle checkpoint by survivin
Li, F., Ambrosini, G., Chu, E. Y., Plescia, J., Tognin, S., Marchisio, P. C., & Altieri, D. C. (1998) · Nature · doi:10.1038/25141 · Cited by 1,870
IAP proteins: blocking the road to death's door
Salvesen, G. S., & Duckett, C. S. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm830 · Cited by 1,756 · cited 2×
“Those studies lead to the identification of two groups of apoptotic ‘brakes’: IAPs and FLIPs (FLICE inhibitory proteins) later found overexpressed in multiple tumor types (Tschopp et al., 1998; Salvesen and Duckett, 2002).”
BackgroundFour deaths and a funeral: from caspases to alternative mechanisms
Leist, M., & Jäättelä, M. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35085008 · Cited by 1,587
A Matter of Life and Cell Death
Evan, G., & Littlewood, T. (1998) · Science · doi:10.1126/science.281.5381.1317 · Cited by 1,523
Beere, H. M., Wolf, B. B., Cain, K., Mosser, D. D., Mahboubi, A., Kuwana, T., Tailor, P., Morimoto, R. I., Cohen, G. M., & Green, D. R. (2000) · Nature Cell Biology · doi:10.1038/35019501 · Cited by 1,511
Control of oncogenesis and cancer therapy resistance by the transcription factor NF-κB
Baldwin, A. S. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11991 · Cited by 1,434
Strasser, A., O'Connor, L., & Dixit, V. M. (2000) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.69.1.217 · Cited by 1,351
Green, D. R., & Evan, G. I. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00024-7 · Cited by 1,254 · cited 1×
“It has been argued that inactivation of apoptotic factors acting downstream cyt c may delay cell death, but will confer little long-term survival advantage (Green and Evan, 2002).”
BackgroundHodgkinson, C. A., Moore, K. J., Nakayama, A., Steingrímsson, E., Copeland, N. G., Jenkins, N. A., & Arnheiter, H. (1993) · Cell · doi:10.1016/0092-8674(93)90429-t · Cited by 1,094
A Senescence Program Controlled by p53 and p16INK4a Contributes to the Outcome of Cancer Therapy
Schmitt, C. A., Fridman, J. S., Yang, M., Lee, S., Baranov, E., Hoffman, R. M., & Lowe, S. W. (2002) · Cell · doi:10.1016/s0092-8674(02)00734-1 · Cited by 1,050
Self-citationDisruption of p53 in human cancer cells alters the responses to therapeutic agents.
Bunz, F., Hwang, P. M., Torrance, C., Waldman, T., Zhang, Y., Dillehay, L., Williams, J., Lengauer, C., Kinzler, K. W., & Vogelstein, B. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6863 · Cited by 1,044 · cited 1×
“One explanation for this paradox is that p53 does not influence treatment responses in this tumor type or, indeed, loss of p53 actually increases drug sensitivity as has been observed in some experimental contexts (Bunz et al., 1999).”
BackgroundInactivation of the apoptosis effector Apaf-1 in malignant melanoma
Soengas, M. S., Capodieci, P., Polsky, D., Mora, J., Esteller, M., Opitz-Araya, X., McCombie, R., Herman, J. G., Gerald, W. L., Lazebnik, Y. A., et al. (2001) · Nature · doi:10.1038/35051606 · Cited by 966
Self-citationThe Fas Signaling Pathway: More Than a Paradigm
Wajant, H. (2002) · Science · doi:10.1126/science.1071553 · Cited by 957
Regulation of PTEN Transcription by p53
Stambolic, V., MacPherson, D., Sas, D., Lin, Y., Snow, B., Jang, Y., Benchimol, S., & Mak, T. W. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00323-9 · Cited by 912
Three-Dimensional Structure of the Apoptosome
Acehan, D., Jiang, X., Morgan, D. G., Heuser, J. E., Wang, X., & Akey, C. W. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00442-2 · Cited by 911
Essential role for oncogenic Ras in tumour maintenance
Chin, L., Tam, A., Pomerantz, J., Wong, M., Holash, J., Bardeesy, N., Shen, Q., O'Hagan, R., Pantginis, J., Zhou, H., et al. (1999) · Nature · doi:10.1038/22788 · Cited by 875
Heat-shock protein 70 antagonizes apoptosis-inducing factor
Ravagnan, L., Gurbuxani, S., Susin, S. A., Maisse, C., Daugas, E., Zamzami, N., Mak, T., Jäättelä, M., Penninger, J. M., Garrido, C., et al. (2001) · Nature Cell Biology · doi:10.1038/ncb0901-839 · Cited by 858
Negative regulation of the Apaf-1 apoptosome by Hsp70
Saleh, A., Srinivasula, S. M., Balkir, L., Robbins, P. D., & Alnemri, E. S. (2000) · Nature Cell Biology · doi:10.1038/35019510 · Cited by 823
The central executioners of apoptosis: caspases or mitochondria?
Green, D., & Kroemer, G. (1998) · Trends in Cell Biology · doi:10.1016/s0962-8924(98)01273-2 · Cited by 766
McGill, G. G., Horstmann, M., Widlund, H. R., Du, J., Motyckova, G., Nishimura, E. K., Lin, Y.-L., Ramaswamy, S., Avery, W., Ding, H.-F., et al. (2002) · Cell · doi:10.1016/s0092-8674(02)00762-6 · Cited by 760
NEW EMBO MEMBERS' REVIEW: Lysosomal cysteine proteases: facts and opportunities
Turk, V. (2001) · The EMBO Journal · doi:10.1093/emboj/20.17.4629 · Cited by 756
Müller, H., Bracken, A. P., Vernell, R., Moroni, M. C., Christians, F., Grassilli, E., Prosperini, E., Vigo, E., Oliner, J. D., & Helin, K. (2001) · Genes & Development · doi:10.1101/gad.864201 · Cited by 751
Requirement for Caspase-2 in Stress-Induced Apoptosis Before Mitochondrial Permeabilization
Lassus, P., Opitz-Araya, X., & Lazebnik, Y. (2002) · Science · doi:10.1126/science.1074721 · Cited by 719
Apaf-1 and Caspase-9 in p53-Dependent Apoptosis and Tumor Inhibition
Soengas, M. S., Alarcón, R. M., Yoshida, H., J., A., Giaccia, Hakem, R., Mak, T. W., & Lowe, S. W. (1999) · Science · doi:10.1126/science.284.5411.156 · Cited by 660
Self-citationNF-κB as a therapeutic target in cancer
Orlowski, R. Z., & Baldwin, A. S. (2002) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(02)02375-4 · Cited by 553
Identification of small-molecule inhibitors of interaction between the BH3 domain and Bcl-xL
Degterev, A., Lugovskoy, A., Cardone, M., Mulley, B., Wagner, G., Mitchison, T., & Yuan, J. (2001) · Nature Cell Biology · doi:10.1038/35055085 · Cited by 550
Caspase-2 Induces Apoptosis by Releasing Proapoptotic Proteins from Mitochondria
Guo, Y., Srinivasula, S. M., Druilhe, A., Fernandes-Alnemri, T., & Alnemri, E. S. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m108029200 · Cited by 521
Inhibition of Fas death signals by FLIPs
Tschopp, J., Irmler, M., & Thome, M. (1998) · Current Opinion in Immunology · doi:10.1016/s0952-7915(98)80223-9 · Cited by 520
Dissecting p53 tumor suppressor functions in vivo
Schmitt, C. A., Fridman, J. S., Yang, M., Baranov, E., Hoffman, R. M., & Lowe, S. W. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00047-8 · Cited by 485
Self-citationChemosensitisation of malignant melanoma by BCL2 antisense therapy
Jansen, B., Wacheck, V, Heere-Ress, E., Schlagbauer-Wadl, H., Hoeller, C., Lucas, T., Hoermann, M., Hollenstein, U., Wolff, K., & Pehamberger, H. (2000) · The Lancet · doi:10.1016/s0140-6736(00)03207-4 · Cited by 482
bcl-2 antisense therapy chemosensitizes human melanoma in SCID mice
Jansen, B., Schlagbauer-Wadl, H., Brown, B. D., Bryan, R. N., Van Elsas, A., Müller, M., Wolff, K., Eichler, H.-G., & Pehamberger, H. (1998) · Nature Medicine · doi:10.1038/nm0298-232 · Cited by 481
PTEN and Myotubularin: Novel Phosphoinositide Phosphatases
Maehama, T., Taylor, G. S., & Dixon, J. E. (2001) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.70.1.247 · Cited by 461
Livin, a Novel Inhibitor of Apoptosis Protein Family Member
Kasof, G. M., & Gomes, B. C. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m003670200 · Cited by 454
Stress management – heat shock protein-70 and the regulation of apoptosis
Beere, H. (2001) · Trends in Cell Biology · doi:10.1016/s0962-8924(00)01874-2 · Cited by 435
Direct coupling of the cell cycle and cell death machinery by E2F
Nahle, Z., Polakoff, J., Davuluri, R. V., McCurrach, M. E., Jacobson, M. D., Narita, M., Zhang, M. Q., Lazebnik, Y., Bar-Sagi, D., & Lowe, S. W. (2002) · Nature Cell Biology · doi:10.1038/ncb868 · Cited by 421
Self-citationML-IAP, a novel inhibitor of apoptosis that is preferentially expressed in human melanomas
Vucic, D., Stennicke, H. R., Pisabarro, M. T., Salvesen, G. S., & Dixit, V. M. (2000) · Current Biology · doi:10.1016/s0960-9822(00)00781-8 · Cited by 414
Robertson, J. D., Enoksson, M., Suomela, M., Zhivotovsky, B., & Orrenius, S. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204185200 · Cited by 409
Induction of Apoptosis and Inhibition of Cell Proliferation bysurvivin Gene Targeting
Ambrosini, G., Adida, C., Sirugo, G., & Altieri, D. C. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.18.11177 · Cited by 406
Cooperative effects of INK4a and ras in melanoma susceptibility in vivo
Chin, L., Pomerantz, J., Polsky, D., Jacobson, M., Cohen, C., Cordon-Cardo, C., Horner, J. W., & DePinho, R. A. (1997) · Genes & Development · doi:10.1101/gad.11.21.2822 · Cited by 402
Expression and Targeting of the Apoptosis Inhibitor, Survivin, in Human Melanoma
Grossman, D., McNiff, J. M., Li, F., & Altieri, D. C. (1999) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.1999.00776.x · Cited by 365
Hsu, M.-Y., Meier, F. E., Nesbit, M., Hsu, J.-Y., Van Belle, P., Elder, D. E., & Herlyn, M. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65023-7 · Cited by 363
Programmed cell death and apoptosis: origins of the theory
Lockshin, R. A., & Zakeri, Z. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35080097 · Cited by 361
PTEN Protects p53 from Mdm2 and Sensitizes Cancer Cells to Chemotherapy
Mayo, L. D., Dixon, J. E., Durden, D. L., Tonks, N. K., & Donner, D. B. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m108302200 · Cited by 351
Cancer gene therapy: fringe or cutting edge?
McCormick, F. (2001) · Nature Reviews Cancer · doi:10.1038/35101008 · Cited by 346
Cancer gene therapy using a survivin mutant adenovirus
Mesri, M., Wall, N. R., Li, J., Kim, R. W., & Altieri, D. C. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12983 · Cited by 337
Apoptosis-regulating proteins as targets for drug discovery
Reed, J. C. (2001) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(01)02026-3 · Cited by 328
Discovery of Small-Molecule Inhibitors of Bcl-2 through Structure-Based Computer Screening
Enyedy, I. J., Ling, Y., Nacro, K., Tomita, Y., Wu, X., Cao, Y., Guo, R., Li, B., Zhu, X., Huang, Y., et al. (2001) · Journal of Medicinal Chemistry · doi:10.1021/jm010016f · Cited by 315
Molecular determinants of terminal growth arrest induced in tumor cells by a chemotherapeutic agent
Chang, B.-D., Swift, M. E., Shen, M., Fang, J., Broude, E. V., & Roninson, I. B. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.012602599 · Cited by 312
Martinou, I., Desagher, S., Eskes, R., Antonsson, B., André, E., Fakan, S., & Martinou, J.-C. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.144.5.883 · Cited by 307
Erhardt, P., Schremser, E. J., & Cooper, G. M. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.8.5308 · Cited by 306
Sarkar, D., Su, Z.-Z., Lebedeva, I. V., Sauane, M., Gopalkrishnan, R. V., Valerie, K., Dent, P., & Fisher, P. B. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.152327199 · Cited by 304
Abrogation of oncogene-associated apoptosis allows transformation of p53-deficient cells.
Lowe, S. W., Jacks, T., Housman, D. E., & Ruley, H. E. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.6.2026 · Cited by 287
Self-citationInhibition of melanoma tumor growth in vivo by survivin targeting
Grossman, D., Kim, P. J., Schechner, J. S., & Altieri, D. C. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.2.635 · Cited by 286
Wang, Y., & Becker, D. (1997) · Nature Medicine · doi:10.1038/nm0897-887 · Cited by 284
Epigenetic PTEN Silencing in Malignant Melanomas without PTEN Mutation
Zhou, X.-P., Gimm, O., Hampel, H., Niemann, T., Walker, M. J., & Eng, C. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64627-5 · Cited by 278
A Novel NF-κB-inducing Kinase-MAPK Signaling Pathway Up-regulates NF-κB Activity in Melanoma Cells
Dhawan, P., & Richmond, A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m112210200 · Cited by 267
Becker, D., Meier, C. B., & Herlyn, M. (1989) · The EMBO Journal · doi:10.1002/j.1460-2075.1989.tb08543.x · Cited by 263
Caudell, E. G., Mumm, J. B., Poindexter, N., Ekmekcioglu, S., Mhashilkar, A. M., Yang, X. H., Retter, M. W., Hill, P., Chada, S., & Grimm, E. A. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.12.6041 · Cited by 262
Noncaspase proteases in apoptosis
Johnson, D. (2000) · Leukemia · doi:10.1038/sj.leu.2401879 · Cited by 250
RAS pathways to cell cycle control and cell transformation
Pellicer, A. (1998) · Frontiers in Bioscience · doi:10.2741/a331 · Cited by 248
The Survivin saga goes in vivo
Reed, J. C. (2001) · Journal of Clinical Investigation · doi:10.1172/jci14123 · Cited by 232
Melanoma–stroma interactions: structural and functional aspects
Ruiter, D., Bogenrieder, T., Elder, D., & Herlyn, M. (2002) · The Lancet Oncology · doi:10.1016/s1470-2045(01)00620-9 · Cited by 231
Fulda, S., Meyer, E., Friesen, C., Susin, S. A., Kroemer, G., & Debatin, K.-M. (2001) · Oncogene · doi:10.1038/sj.onc.1204141 · Cited by 223
Drug Resistance in Melanoma: Mechanisms, Apoptosis, and New Potential Therapeutic Targets
Grossman, D., & Altieri, D. C. (2001) · Cancer and Metastasis Reviews · doi:10.1023/a:1013123532723 · Cited by 218
Apoptosis in cancer: cause and cure
Kaufmann, S. H., & Gores, G. J. (2000) · BioEssays · doi:10.1002/1521-1878(200011)22:11<1007::aid-bies7>3.0.co;2-4 · Cited by 214
How melanoma cells evade trail-induced apoptosis
Hersey, P., & Zhang, X. D. (2001) · Nature Reviews Cancer · doi:10.1038/35101078 · Cited by 212
Proteasome inhibition in cancer: Development of PS-341
ADAMS, J. (2001) · Seminars in Oncology · doi:10.1016/s0093-7754(01)90034-x · Cited by 209
Bcl-2 family proteins as targets for anticancer drug design
Huang, Z. (2000) · Oncogene · doi:10.1038/sj.onc.1204087 · Cited by 201
Lowe, S. W. (1995) · Current Opinion in ONCOLOGY · doi:10.1097/00001622-199511000-00013 · Cited by 194
Self-citationMalignant melanoma: modern black plague and genetic black box
Chin, L., Merlino, G., & DePinho, R. A. (1998) · Genes & Development · doi:10.1101/gad.12.22.3467 · Cited by 194
Drug-resistance in human melanoma
Helmbach, H., Rossmann, E., Kern, M. A., & Schadendorf, D. (2001) · International Journal of Cancer · doi:10.1002/ijc.1378 · Cited by 190
Modern Pharmacology with Clinical Applications
Mucklow, J. (2004) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2004.02140.x · Cited by 189
Whiteman, D. C., Zhou, X., Cummings, M. C., Pavey, S., Hayward, N. K., & Eng, C. (2002) · International Journal of Cancer · doi:10.1002/ijc.10294 · Cited by 187
Deshmukh, M., Kuida, K., & Johnson, E. M. (2000) · The Journal of Cell Biology · doi:10.1083/jcb.150.1.131 · Cited by 184
Inhibition of MDM2 by hsp90 Contributes to Mutant p53 Stabilization
Peng, Y., Chen, L., Li, C., Lu, W., & Chen, J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m102817200 · Cited by 183
Proteasome inhibition: a novel approach to cancer therapy
Adams, J. (2002) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(02)02315-8 · Cited by 180
Pds1 phosphorylation in response to DNA damage is essential for its DNA damage checkpoint function
Wang, H., Liu, D., Wang, Y., Qin, J., & Elledge, S. J. (2001) · Genes & Development · doi:10.1101/gad.893201 · Cited by 173
Epigenomics and epigenetic therapy of cancer
Brown, R., & Strathdee, G. (2002) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(02)02314-6 · Cited by 172
Genetic analysis of Pten and Ink4a/Arf interactions in the suppression of tumorigenesis in mice
You, M. J., Castrillón, D. H., Bastian, B. C., O’Hagan, R. C., Bosenberg, M., Parsons, R. E., Chin, L., & DePinho, R. A. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.022632099 · Cited by 171
Apaf-1 Is a Mediator of E2F-1-induced Apoptosis
Furukawa, Y., Nishimura, N., Furukawa, Y., Satoh, M., Endo, H., Iwase, S., Yamada, H., Matsuda, M., Kano, Y., & Nakamura, M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200805200 · Cited by 169
King, F. W. (2001) · The EMBO Journal · doi:10.1093/emboj/20.22.6297 · Cited by 167
Blocking Cytochrome c Activity within Intact Neurons Inhibits Apoptosis
Neame, S. J., Rubin, L. L., & Philpott, K. L. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.142.6.1583 · Cited by 163
Melanoma Differentiation Associated Gene-7 (mda-7): A Novel Anti-Tumor Gene for Cancer Gene Therapy
Mhashilkar, A. M., Schrock, R. D., Hindi, M., Liao, J., Sieger, K., Kourouma, F., Zou-Yang, X. H., Onishi, E., Takh, O., Vedvick, T. S., et al. (2001) · Molecular Medicine · doi:10.1007/bf03401847 · Cited by 162
SMAC Negatively Regulates the Anti-apoptotic Activity of Melanoma Inhibitor of Apoptosis (ML-IAP)
Vucic, D., Deshayes, K., Ackerly, H., Pisabarro, M. T., Kadkhodayan, S., Fairbrother, W. J., & Dixit, V. M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m112045200 · Cited by 162
Modern Pharmacology with Clinical Applications
Craig, C. R., & Stitzel, R. E. (2003) · Andalas University Repository (Andalas University) · Cited by 157
Molecular mechanisms of photocarcinogenesis
Matsumura, Y., & Ananthaswamy, H. N. (2002) · Frontiers in bioscience · doi:10.2741/matsumur · Cited by 154
Gautschi, O. P., Tschopp, S., Olie, R. A., Leech, S. H., Simões‐Wüst, A. P., Ziegler, A., Baumann, B., Odermatt, B. F., Hall, J., Stahel, R. A., et al. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.6.463 · Cited by 145
Glinsky, G. V. (1997) · Cancer Letters · doi:10.1016/s0304-3835(97)04738-1 · Cited by 142
Mutation and Allelic Loss of the PTEN/MMAC1 gene in Primary and Metastatic Melanoma Biopsies
Birck, A., Ahrenkiel, V., Zeuthen, J., HOU-JENSEN, K., & Guldberg, P. (2000) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2000.00877.x · Cited by 141
Tumor Type Is a Determinant of Susceptibility to Apoptosis
Staunton, M. J., & Gaffney, E. F. (1995) · American Journal of Clinical Pathology · doi:10.1093/ajcp/103.3.300 · Cited by 136
Cellular resistance to topoisomerase-targeted drugs: from drug uptake to cell death
Larsen, A. K., & Składanowski, A. (1998) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(98)00140-7 · Cited by 126
Zhai, S., Yaar, M., Doyle, S. M., & Gilchrest, B. A. (1996) · Experimental Cell Research · doi:10.1006/excr.1996.0143 · Cited by 121
Kotelevets, L., van Hengel, J., Bruyneel, E. A., Mareel, M. M. K., Roy, F. M. V., & Chastre, E. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.200105109 · Cited by 118
Drug discovery opportunities from apoptosis research
Reed, J. C., & Tomaselli, K. J. (2000) · Current Opinion in Biotechnology · doi:10.1016/s0958-1669(00)00148-8 · Cited by 114
Molecular Regulation of Melanocyte Senescence
Bennett, D. C., & Medrano, E. E. (2002) · Pigment Cell Research · doi:10.1034/j.1600-0749.2002.02036.x · Cited by 111
Selective Expression of FLIP in Malignant Melanocytic Skin Lesions
Bullani, R. R., Huard, B., Viard, I., Saurat, J. ‐., French, L. E., Byers, H. R., Irmler, M., & Tschopp, J. (2001) · Journal of Investigative Dermatology · doi:10.1046/j.0022-202x.2001.01418.x · Cited by 110
Deregulated E2f Transcriptional Activity in Autonomously Growing Melanoma Cells
Halaban, R., Cheng, E., Smicun, Y., & Germino, J. F. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.6.1005 · Cited by 94
Satyamoorthy, K., Muyrers, J. P. P., Meier, F. E., Patel, D., & Herlyn, M. (2001) · Oncogene · doi:10.1038/sj.onc.1204616 · Cited by 91
Identification of PTEN mutations in metastatic melanoma specimens
Çelebi, J. T., Shendrik, I., Silvers, D. N., & Peacocke, M. (2000) · Journal of Medical Genetics · doi:10.1136/jmg.37.9.653 · Cited by 90
Baculovirus interaction with host apoptotic pathways
Miller, L. K. (1997) · Journal of Cellular Physiology · Cited by 90
Unbound states by analytic continuation in the coupling constant
Tanaka, N., Suzuki, Y., Varga, K., & Lovas, R. (1999) · Physical Review C · doi:10.1103/physrevc.59.1391 · Cited by 85
An ATF2-derived peptide sensitizes melanomas to apoptosis and inhibits their growth and metastasis
Bhoumik, A., Huang, T.-G., Ivanov, V. N., Gangi, L., Qiao, R., Woo, S. L. C., Chen, S., & Ronai, Z. A. (2002) · Journal of Clinical Investigation · doi:10.1172/jci16081 · Cited by 84
Olie, R. A., Hafner, C., Küttel, R., Sigrist, B., Stahel, R. A., Zangemeister‐Wittke, U., Willers, J., Dummer, R., & Hall, J. (2002) · Journal of Investigative Dermatology · doi:10.1046/j.0022-202x.2001.01677.x · Cited by 83
McNulty, S. E., Tohidian, N. B., & Meyskens, F. L. (2001) · Pigment Cell Research · doi:10.1034/j.1600-0749.2001.140606.x · Cited by 80
Huang, S., DeGuzman, A., Bucana, C. D., & Fidler, I. J. (2000) · Cytokines Cellular & Molecular Therapy · doi:10.1080/13684730050515868 · Cited by 79
Ugurel, S., Seiter, S., Rappl, G., Stark, A., Tilgen, W., & Reinhold, U. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19990827)82:5<727::aid-ijc17>3.0.co;2-e · Cited by 67
Lage, H., Helmbach, H., Dietel, M., & Schadendorf, D. (2000) · British Journal of Cancer · doi:10.1054/bjoc.1999.0947 · Cited by 64
Bakker, T. R., Reed, D. S., Renno, T., & Jongeneel, C. V. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19990118)80:2<320::aid-ijc24>3.0.co;2-k · Cited by 62
Rieber, M., & RIEBER, M. S. (1998) · DNA and Cell Biology · doi:10.1089/dna.1998.17.399 · Cited by 53
Suppression of the Malignant Phenotype of Melanoma Cells by Anti-Oncogene Ribozymes
Ohta, Y., Kijima, H., Kashani‐Sabet, M., & Scanlon, K. J. (1996) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12340688 · Cited by 46
Mutated N-ras upregulates Bcl-2 in human melanoma in vitro and in SCID mice
Borner, C., Schlagbauer‐Wadl, H., Fellay, I., Selzer, E., Polterauer, P., & Jansen, B. (1999) · Melanoma Research · doi:10.1097/00008390-199908000-00002 · Cited by 45
Overexpression of HSP70 prevents ultraviolet B-induced apoptosis of a human melanoma cell line
Park, K.-C., Kim, D., Choi, H. O., Kim, K., Chung, J. H., Eun, H.-C., Lee, J. S., & Seo, J. (2000) · Archives of Dermatological Research · doi:10.1007/s004030000173 · Cited by 44
Ivanov, V. N., Fodstad, Ø., & Ronai, Z. A. (2001) · Oncogene · doi:10.1038/sj.onc.1204314 · Cited by 43
Kit+ Melanocytes Seem to Contribute to Melanocyte Proliferation After UV Exposure as Precursor Cells
Kawaguchi, Y., Mori, N., & Nakayama, A. (2001) · Journal of Investigative Dermatology · doi:10.1046/j.0022-202x.2001.01370.x · Cited by 39
Enhanced Anti-Tumor Effects with Microencapsulated c- myc Antisense Oligonucleotide
Putney, S. D., Brown, J. N., Cucco, C., Lee, R., Skórski, T., Leonetti, C., Geiser, T., Calabretta, B., Zupi, G., & Zon, G. (1999) · Antisense and Nucleic Acid Drug Development · doi:10.1089/oli.1.1999.9.451 · Cited by 36
Advances in Gene Therapy for Malignant Melanoma
Sotomayor, M. G., Yu, H., Antonia, S. J., Sotomayor, E. M., & Pardoll, D. M. (2002) · Cancer Control · doi:10.1177/107327480200900106 · Cited by 31
Apoptosis: A Role in Skin Aging?
Haake, A. R., Roublevskaia, I., & Cooklis, M. (1998) · Journal of Investigative Dermatology Symposium Proceedings · doi:10.1038/jidsymp.1998.8 · Cited by 30
Wellbrock, C., Fischer, P., & Schartl, M. (1999) · Experimental Cell Research · doi:10.1006/excr.1999.4580 · Cited by 27
Rass, K., Gutwein, P., Welter, C., Meineke, V., Tilgen, W., & Reichrath, J. (2001) · The Histochemical Journal · doi:10.1023/a:1014472314354 · Cited by 25
Apoptosis: A Role in Skin Aging?
Haake, A. R., Roublevskaia, I., & Cooklis, M. (1998) · Journal of Investigative Dermatology · doi:10.1038/jidsp.1998.8 · Cited by 19
Rieber, M., & Strasberg–Rieber, M. (1998) · International Journal of Cancer · Cited by 16
Korabiowska, M., Brinck, U., Kotthaus, I., Berger, H., & Droese, M. (2000) · Melanoma Research · doi:10.1097/00008390-200012000-00005 · Cited by 10
Molecular mechanisms of photocarcinogenesis
Ananthaswamy, H. N. (2002) · Frontiers in bioscience · doi:10.2741/a810 · Cited by 9
Cited by
Melanoma biology and new targeted therapy
Gray-Schopfer, V., Wellbrock, C., & Marais, R. (2007) · Nature · doi:10.1038/nature05661 · Cited by 1,371
MITF: master regulator of melanocyte development and melanoma oncogene
Levy, C., Khaled, M., & Fisher, D. E. (2006) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2006.07.008 · Cited by 1,169
Domingues, B., Lopes, J., Soares, P., & Populo, H. (2018) · ImmunoTargets and Therapy · doi:10.2147/itt.s134842 · Cited by 701
Tom20 senses iron-activated ROS signaling to promote melanoma cell pyroptosis
Zhou, B., Zhang, J.-Y., Liu, X.-S., Chen, H.-Z., Ai, Y.-L., Cheng, K., Sun, R.-Y., Zhou, D., Han, J., & Wu, Q. (2018) · Cell Research · doi:10.1038/s41422-018-0090-y · Cited by 660
Bedikian, A. Y., Millward, M., Pehamberger, H., Conry, R., Gore, M., Trefzer, U., Pavlick, A. C., DeConti, R., Hersh, E. M., Hersey, P., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.06.0483 · Cited by 600
Metadata
- Authors
- Soengas, M. S., & Lowe, S. W.
- Venue
- Oncogene
- Published
- 2003-05-19
- Volume
- 22
- Issue
- 20
- Pages
- 3138-3151
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2152315800
- Cited by
- 826
- References
- 143
- FWCI
- 12.55
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.